FR2282908A1 - Vaccin contre la colibacillose - Google Patents

Vaccin contre la colibacillose

Info

Publication number
FR2282908A1
FR2282908A1 FR7526861A FR7526861A FR2282908A1 FR 2282908 A1 FR2282908 A1 FR 2282908A1 FR 7526861 A FR7526861 A FR 7526861A FR 7526861 A FR7526861 A FR 7526861A FR 2282908 A1 FR2282908 A1 FR 2282908A1
Authority
FR
France
Prior art keywords
vaccine against
against colibacillosis
colibacillosis
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7526861A
Other languages
English (en)
Other versions
FR2282908B1 (fr
Inventor
Michael R Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Patents and Development Ltd
Original Assignee
Canadian Patents and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents and Development Ltd filed Critical Canadian Patents and Development Ltd
Publication of FR2282908A1 publication Critical patent/FR2282908A1/fr
Application granted granted Critical
Publication of FR2282908B1 publication Critical patent/FR2282908B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7526861A 1974-09-02 1975-09-02 Vaccin contre la colibacillose Granted FR2282908A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3827974A GB1472624A (en) 1974-09-02 1974-09-02 Enteric disease vaccine

Publications (2)

Publication Number Publication Date
FR2282908A1 true FR2282908A1 (fr) 1976-03-26
FR2282908B1 FR2282908B1 (fr) 1978-11-10

Family

ID=10402419

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7526861A Granted FR2282908A1 (fr) 1974-09-02 1975-09-02 Vaccin contre la colibacillose

Country Status (9)

Country Link
JP (1) JPS5151514A (fr)
AU (1) AU8440975A (fr)
BE (1) BE832967A (fr)
DE (1) DE2538994A1 (fr)
DK (1) DK386875A (fr)
FR (1) FR2282908A1 (fr)
GB (1) GB1472624A (fr)
NL (1) NL7510120A (fr)
ZA (1) ZA755043B (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028172A3 (en) * 1979-10-03 1981-06-10 Etablissement Public Dit: Institut National De La Recherche Agronomique Anticolibacillary animal vaccine, preparation, application and used escherichia coli strains
FR2481928A1 (fr) * 1980-03-19 1981-11-13 Univ Ramot Nouveaux mutants bacteriens, procede de leur production et vaccins vivants les contenant
EP0060129A2 (fr) * 1981-03-09 1982-09-15 Cetus Corporation Vaccins, procédé de préparation et procédé de stimulation de la production d'anticorps
EP0080806A1 (fr) * 1981-10-22 1983-06-08 Research Corporation Vaccin vivant et méthode pour sa production
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
WO1994005326A1 (fr) * 1992-09-04 1994-03-17 University Of Saskatchewan Nouveaux vaccins bacteriens utilisant des souches vaccinales de bacteries pathogenes

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
NZ205392A (en) * 1982-09-02 1987-03-06 Unilever Plc Preparation of immunoglobulins against e.coli pili
EP0175699A4 (fr) * 1984-02-01 1988-06-13 Enterovax Res Pty Ltd Souches bacteriennes.
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE9100556D0 (sv) * 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOLUME 77, 15255A 1972 *
CHEMICAL ABSTRACTS, VOLUME 78, 41434Y 1973 ) *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028172A3 (en) * 1979-10-03 1981-06-10 Etablissement Public Dit: Institut National De La Recherche Agronomique Anticolibacillary animal vaccine, preparation, application and used escherichia coli strains
FR2481928A1 (fr) * 1980-03-19 1981-11-13 Univ Ramot Nouveaux mutants bacteriens, procede de leur production et vaccins vivants les contenant
EP0060129A2 (fr) * 1981-03-09 1982-09-15 Cetus Corporation Vaccins, procédé de préparation et procédé de stimulation de la production d'anticorps
EP0060129A3 (en) * 1981-03-09 1983-06-01 Cetus Corporation Vaccines, a method for making vaccines and a method for stimulating antibody production
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
EP0080806A1 (fr) * 1981-10-22 1983-06-08 Research Corporation Vaccin vivant et méthode pour sa production
WO1994005326A1 (fr) * 1992-09-04 1994-03-17 University Of Saskatchewan Nouveaux vaccins bacteriens utilisant des souches vaccinales de bacteries pathogenes

Also Published As

Publication number Publication date
AU8440975A (en) 1977-03-03
JPS5151514A (en) 1976-05-07
ZA755043B (en) 1976-06-30
FR2282908B1 (fr) 1978-11-10
GB1472624A (en) 1977-05-04
DE2538994A1 (de) 1976-06-16
NL7510120A (nl) 1976-03-04
DK386875A (da) 1976-03-03
BE832967A (fr) 1975-12-31

Similar Documents

Publication Publication Date Title
DK128675A (de) Pharmazeutische zusammensetzung
BE827352A (fr) Cagoule chirurgicale
IT1028944B (it) Siringa dentistica
SE7604818L (sv) Vaccin
BE787901A (fr) Vaccin antivariolique
IT1042173B (it) Procedimento per preparare butandioli
NL7505240A (nl) Farmaceutisch preparaat.
FR2282908A1 (fr) Vaccin contre la colibacillose
DK524175A (da) Bendiazepinderivater
IT1050317B (it) Procedimento di decaffeinizzazione
IT1041312B (it) Procedimento per la preparazione di poliolefine
SE7510752L (sv) Galenisk beredning for allopyrinol-langtidsterapi
BE820042A (fr) Vaccin contre la leucemie des felins
SE7800781L (sv) Nytt vaccin
AT348137B (de) Desinfektionsmittel-zubereitung
IT1039978B (it) Chiodo
BE794307A (fr) Vaccin anti-caries
AU500250B2 (en) Influenza vaccine
SE7513007L (sv) Cykliska forfamid-derivat
DK183575A (da) Preparater med antioxidativ virkning
FR2305195A1 (fr) Vaccin polysaccharide de meningocoque
BE827157A (fr) Vaccin contre la rhinotracheite feline et sa production
SE7813201L (sv) Vaccin
SE7513298L (sv) Diaryloxi-imidazolyl-o,n-acetaler till anvendning som lekemedel och sett for deras framstellning
BR7506336A (pt) Seringa

Legal Events

Date Code Title Description
ST Notification of lapse